Ultra Clean (UCTT) | Financial Analysis & Statements
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
2.1B
Gross Profit
356.3M
16.99%
Operating Income
91.2M
4.35%
Net Income
34.5M
1.64%
Balance Sheet Metrics
Total Assets
1.9B
Total Liabilities
984.1M
Shareholders Equity
935.8M
Debt to Equity
1.05
Cash Flow Metrics
Operating Cash Flow
92.8M
Free Cash Flow
1.5M
Revenue & Profitability Trend
Ultra Clean Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 2.1B | 1.7B | 2.4B | 2.1B | 1.4B |
| Cost of Goods Sold | 1.7B | 1.5B | 1.9B | 1.7B | 1.1B |
| Gross Profit | 356.3M | 277.3M | 465.0M | 430.0M | 291.8M |
| Operating Expenses | 265.1M | 242.1M | 267.2M | 244.3M | 170.4M |
| Operating Income | 91.2M | 35.2M | 197.8M | 185.7M | 121.4M |
| Pre-tax Income | 67.2M | -11.3M | 88.3M | 154.3M | 99.7M |
| Income Tax | 32.7M | 10.9M | 37.9M | 27.9M | 19.3M |
| Net Income | 34.5M | -22.2M | 50.4M | 126.4M | 80.4M |
| EPS (Diluted) | - | -$0.70 | $0.88 | $2.69 | $1.89 |
Income Statement Trend
Ultra Clean Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 970.1M | 893.2M | 1.1B | 1.1B | 545.1M |
| Non-Current Assets | 949.8M | 974.5M | 862.1M | 888.3M | 557.4M |
| Total Assets | 1.9B | 1.9B | 2.0B | 2.0B | 1.1B |
| Liabilities | |||||
| Current Liabilities | 335.6M | 310.0M | 389.2M | 469.1M | 201.2M |
| Non-Current Liabilities | 648.5M | 660.5M | 634.7M | 663.6M | 350.1M |
| Total Liabilities | 984.1M | 970.5M | 1.0B | 1.1B | 551.3M |
| Equity | |||||
| Total Shareholders Equity | 935.8M | 897.2M | 937.0M | 892.7M | 551.2M |
Balance Sheet Composition
Ultra Clean Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 34.5M | -22.2M | 50.4M | 126.4M | 80.4M |
| Operating Cash Flow | 92.8M | 133.4M | -33.5M | 193.7M | 77.3M |
| Investing Activities | |||||
| Capital Expenditures | -63.5M | -73.6M | -99.6M | -51.6M | -29.8M |
| Investing Cash Flow | -63.5M | -119.7M | -96.2M | -415.2M | -29.8M |
| Financing Activities | |||||
| Dividends Paid | -500.0K | - | - | 0 | 0 |
| Financing Cash Flow | 9.8M | -69.9M | -56.0M | 460.8M | -31.1M |
| Free Cash Flow | 1.5M | 60.1M | -52.9M | 152.3M | 60.9M |
Cash Flow Trend
Ultra Clean Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
40.74
Forward P/E
9.12
Price to Book
1.31
Price to Sales
0.53
PEG Ratio
9.12
Profitability Ratios
Profit Margin
1.31%
Operating Margin
2.49%
Return on Equity
4.29%
Return on Assets
2.91%
Financial Health
Current Ratio
3.03
Debt to Equity
69.00
Beta
2.05
Per Share Data
EPS (TTM)
$0.62
Book Value per Share
$19.34
Revenue per Share
$47.50
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| uctt | 1.1B | 40.74 | 1.31 | 4.29% | 1.31% | 69.00 |
| Applied Materials | 156.6B | 23.75 | 8.26 | 36.37% | 24.06% | 35.18 |
| Lam Research | 127.7B | 27.81 | 13.47 | 53.14% | 27.19% | 47.15 |
| Axcelis | 2.4B | 13.51 | 2.31 | 18.45% | 18.58% | 7.05 |
| Kulicke & Soffa | 2.0B | 100.05 | 2.27 | 2.29% | 3.11% | 4.20 |
| Acm Research | 1.8B | 18.08 | 1.91 | 12.68% | 13.28% | 20.53 |
Financial data is updated regularly. All figures are in the company's reporting currency.